Sectoral ETFs In India: Banking, IT, PSU, And Pharma Explained

Last Reviewed and Updated: 17 Aug 2026

A broad market ETF, tracking the Nifty 50 or Nifty 500, spreads risk across dozens or hundreds of companies in many industries. A sectoral ETF deliberately gives that up, concentrating entirely in one industry's stocks to let an investor make a specific, targeted bet rather than a broad one.

The general mechanics of buying, checking liquidity, and reading tracking error, covered in earlier articles in this series, apply the same way to a sectoral ETF as to any other. What genuinely differs is how each sector actually behaves, and why.

Banking: Nifty Bank

A Nifty Bank ETF tracks India's largest, most liquid banking companies, spanning both private and public sector banks. Its performance is driven primarily by credit growth, interest rate cycles, and asset quality trends across the sector, and it reacts quickly to Reserve Bank of India policy changes specifically, since a shift in interest rates or lending regulation moves the economics of every bank in the index at roughly the same time.

PSU Banks: A Narrower, More Cyclical Slice Of Banking

A Nifty PSU Bank ETF is a genuinely different, narrower bet than the broader Bank Nifty, tracking only government owned banks.

The cyclicality here is real and worth seeing in numbers rather than description alone: one established PSU Bank ETF has posted a 5 year return above 37% and a 1 year return above 32%, an outstanding recent stretch, alongside a 10 year return of just over 12%, reflecting a long period of considerably weaker performance before that recent turnaround.

The same index family, held over different windows, tells a genuinely different story depending on exactly when you started.

The same PSU bank index that returned over 37% across the last five years managed barely 12% across the last ten. Both numbers are true. Neither one alone tells you what actually happened in between.

Time Window	Reported Return
1 year	Above 32%
3 years	Above 26%
5 years	Above 37%
10 years	Just above 12%

Figures reflect one established PSU Bank ETF's reported returns at a specific point in 2026, illustrative of the category's cyclicality rather than a current, live quote. The wide gap between the 10 year figure and the more recent windows reflects a long stretch of weaker performance before a strong recent turnaround, not a data error.

IT: Nifty IT

A Nifty IT ETF tracks India's major information technology services exporters. Its performance is closely tied to the rupee to dollar exchange rate and global technology spending cycles, since revenue for this sector is heavily export driven and priced in foreign currency, a fundamentally different macro sensitivity than a bank ETF has.

A weakening rupee can flatter reported earnings even when underlying demand is soft, and a global slowdown in technology spending can weigh on the sector even when the rupee is stable.

Pharma And Healthcare: Two Related But Different Indices

Pharmaceutical sector exposure in India actually comes through two related but distinct indices, the Nifty Pharma Index and the separate Nifty Healthcare Index, and it is worth checking which one a specific ETF actually tracks rather than assuming they are interchangeable.

Holdings commonly include Sun Pharma, Cipla, and Dr Reddy's among other major names. Performance is driven by generic drug demand, the growth of contract manufacturing for global pharmaceutical companies, export potential, and regulatory approval cycles, both from Indian authorities and from bodies like the US FDA for export focused companies.

Not Every PSU Or Sector Bet Has Worked

The strong PSU Bank numbers above should not be read as evidence that anything carrying a PSU label performs similarly.

A separate, newer PSU focused ETF, launched in May 2024 and carrying an unusually low 0.20% expense ratio, has posted a modest 5.80% return over 1 year and an actual loss of 1.29% since its launch.

Low cost and a PSU label are not, on their own, any guarantee of the kind of outcome the established PSU Bank index has delivered recently. The specific underlying index, not the general sector label, is what actually determines the outcome.

The Risks Common To All Four

● Concentration. A downturn specific to one sector hits a sectoral ETF harder and faster than it would hit a diversified fund with no exposure to avoid it.

● Policy sensitivity. Banking regulation, PSU disinvestment policy, and pharmaceutical regulatory approvals can each move an entire sector's ETF at once, in a way no single company specific event could.

● Short term volatility can run large even when the longer term story for a given sector looks constructive, exactly what the PSU Bank ETF's 5 year versus 10 year gap illustrates directly.

Sector	What It Tracks	Key Driver
Banking	Nifty Bank, both private and public sector banks	Credit growth, interest rate cycles, RBI policy
PSU Banks	Nifty PSU Bank, government owned banks only	Government policy, asset quality cycles, historically more volatile than banking broadly
IT	Nifty IT, major technology services exporters	Rupee to dollar exchange rate, global technology spending
Pharma and Healthcare	Nifty Pharma or the separate Nifty Healthcare Index	Generic drug demand, contract manufacturing growth, regulatory approvals

Note: PSU exposure itself is not one single thing. A PSU Bank ETF and a broader PSU enterprise ETF track genuinely different indices with different constituents and different behaviour, a distinction covered in more depth in a dedicated article later in this series comparing CPSE ETFs and Nifty PSU Bank ETFs directly. This piece introduces all four major sector categories at a survey level.

This article is for general informational purposes only and does not constitute investment advice. Sectoral ETFs carry concentration risk and can be more volatile than diversified equity funds. Returns, AUM, and expense ratios cited here reflect figures reported at specific points in 2026 and change over time. Consult a qualified financial adviser before making any investment decision.

Disclaimer

The content on this website is for informational and educational purposes only and should not be construed as investment advice, a recommendation, or a solicitation to buy or sell any security, mutual fund, or financial instrument. Equity Research India is not a SEBI-registered investment advisor or research analyst, and nothing on this site constitutes personalized financial advice.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing. Past performance is not indicative of future returns. NAV, returns, rankings, and other data may change and may not reflect the most current information at the time of reading.

Readers should conduct their own due diligence and consult a SEBI-registered financial advisor before making any investment decisions. Equity Research India and its authors accept no liability for any loss or damage arising from the use of this content.